Aeglea BioTherapeutics Inc. Stock Price (AGLE)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

ROBO Global Healthcare Technology ETF Debuts on NYSETue, 25 Jun 2019 17:14:12 UTC via ETF Trends
Amarin Corporation plc. (AMRN) CEO John Thero Presents at 2019 BMO Prescription For Success Healthcare Conference (Transcript)Tue, 25 Jun 2019 15:27:03 UTC via Seeking Alpha
ROBO Global ‘HTEC’ ETF Focuses on Disruptive Healthcare IndustryTue, 25 Jun 2019 15:18:54 UTC via ETF Trends
Ionis Pharmaceuticals, Inc. (IONS) Management on BMO Prescription for Success Healthcare Conference (Transcript)Tue, 25 Jun 2019 14:32:36 UTC via Seeking Alpha
Sienna Biopharmaceuticals (SNNA) Presents At BMO 2019 Prescriptions For Success Healthcare Conference - SlideshowTue, 25 Jun 2019 13:36:37 UTC via Seeking Alpha
Webcast: Investing in Healthcare Tech & InnovationTue, 25 Jun 2019 10:38:19 UTC via ETF Trends
BMO Prescriptions for Success Healthcare Conference PresentationTue, 25 Jun 2019 09:58:04 UTC via Seeking Alpha
In Case Omega Healthcare Is Beyond SavingSun, 23 Jun 2019 15:19:28 UTC via Seeking Alpha
Rep. Swalwell: Healthcare is the number one issue for votersSat, 22 Jun 2019 15:59:33 UTC via MSNBC
Evotec (EVTCY) Presents At Jefferies 2019 Healthcare Conference - SlideshowFri, 21 Jun 2019 16:15:18 UTC via Seeking Alpha

Aeglea BioTherapeutics Inc. Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:AGLE

You don't have any alerts set for IEX:AGLE.

About Aeglea BioTherapeutics Inc.

Aeglea BioTherapeutics Inc is a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism, which will transform the lives of patients with inborn errors of metabolism and cancer.

CEOAnthony G. Quinn IndustryBiotechnology SectorHealthcare Websitehttps://www.aegleabio.com Issue ExchangeNASDAQ Global Market Issue TypeUnknown

Real-time AGLE to USD Trade Analysis on IEX

Market Status Open

Time Elapsed

Trades Analyzed

Last Price

Trades per Minute

Volume per Trade Average

Volume per Minute Average

Largest Trade Volume

Largest Trade Cost

Total Volume

Total Buy Volume

Total Sell Volume

Buy to Sell Volume

Buy to Sell Trades

USD per Trade Average

USD per Minute Average

USD Total Volume

Buy/Sell stats are based on the side that filled the order.

Real-time Trade History

Waiting for IEX trades to start ...

The last recorded trade was over an hour ago.